BAME babies at highest risk of Vitamin D deficiency

A third of all babies and half of Black, Asian and Minority Ethnic (BAME) babies are vitamin D deficient, a large study of 3,000 newborns in the West Midlands has shown, highlighting potential shortfalls in the current UK antenatal supplementation programme. Vitamin D, sometimes referred to as the ‘sunshine vitamin’ helps the body absorb calcium … Continue reading “BAME babies at highest risk of Vitamin D deficiency”

Study finds paediatric cancer patients at no greater risk of severe COVID-19 infection

Results from the first national study of children with cancer who test positive from COVID-19 has found that these patients do not appear to be at any increased risk of severe COVID-19 infection compared to healthy children. Led by BHP founder-member the University of Birmingham, the study analysed the severity of COVID-19 infection in children with … Continue reading “Study finds paediatric cancer patients at no greater risk of severe COVID-19 infection”

Novel approach to clinical trials could prove ‘transformational’

Funded by the National Institute for Health Research (NIHR) and the Department of Health and Social Care, DaRe2THINK is an entirely new way of running large clinical trials for patient benefit in the NHS. Using innovations focused on data privacy and the security of health information, this approach will allow us to run clinical trials … Continue reading “Novel approach to clinical trials could prove ‘transformational’”

New treatment could spare early-stage rectal cancer patients life-altering side effects

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects, results from a pilot study show. Results from the TREC trial show that a combination of local keyhole surgery and radiotherapy, … Continue reading “New treatment could spare early-stage rectal cancer patients life-altering side effects”

Landmark non-alcoholic fatty liver disease trial identifies new treatment

An international trial, with Birmingham providing one of the lead investigators, has identified a potential drug therapy to reverse non-alcoholic fatty liver disease – a condition for which there is currently no approved treatment. Non-alcoholic fatty liver disease or non-alcoholic steatohepatitis (NASH) is commonly found in individuals with high body weight and diabetes. The condition … Continue reading “Landmark non-alcoholic fatty liver disease trial identifies new treatment”